ADMA
Price
$9.23
Change
-$0.16 (-1.70%)
Updated
Sep 11 closing price
Capitalization
2.07B
60 days until earnings call
Intraday BUY SELL Signals
ARTL
Price
$5.43
Change
-$0.20 (-3.55%)
Updated
Sep 11 closing price
Capitalization
2.93M
66 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ADMA vs ARTL

ADMA vs ARTL Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
ADMA vs. ARTL commentary
Sep 13, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ADMA is a StrongBuy and ARTL is a StrongBuy.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ADMA($2.07B) has a higher market cap than ARTL($2.93M). ADMA YTD gains are higher at: -49.397 vs. ARTL (-83.515). ADMA has higher annual earnings (EBITDA): 233M vs. ARTL (-12.34M). ADMA has more cash in the bank: 136M vs. ARTL (4.2M). ARTL has less debt than ADMA: ARTL (49K) vs ADMA (204M). ADMA has higher revenues than ARTL: ADMA (512M) vs ARTL (0).
ADMAARTLADMA / ARTL
Capitalization2.07B2.93M70,556%
EBITDA233M-12.34M-1,889%
Gain YTD-49.397-83.51559%
P/E Ratio13.19N/A-
Revenue512M0-
Total Cash136M4.2M3,240%
Total Debt204M49K416,327%
FUNDAMENTALS RATINGS
ADMA vs ARTL: Fundamental Ratings
ADMA
ARTL
OUTLOOK RATING
1..100
6078
VALUATION
overvalued / fair valued / undervalued
1..100
71
Overvalued
8
Undervalued
PROFIT vs RISK RATING
1..100
70100
SMR RATING
1..100
25100
PRICE GROWTH RATING
1..100
6393
P/E GROWTH RATING
1..100
78100
SEASONALITY SCORE
1..100
85n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ARTL's Valuation (8) in the null industry is somewhat better than the same rating for ADMA (71) in the Biotechnology industry. This means that ARTL’s stock grew somewhat faster than ADMA’s over the last 12 months.

ADMA's Profit vs Risk Rating (70) in the Biotechnology industry is in the same range as ARTL (100) in the null industry. This means that ADMA’s stock grew similarly to ARTL’s over the last 12 months.

ADMA's SMR Rating (25) in the Biotechnology industry is significantly better than the same rating for ARTL (100) in the null industry. This means that ADMA’s stock grew significantly faster than ARTL’s over the last 12 months.

ADMA's Price Growth Rating (63) in the Biotechnology industry is in the same range as ARTL (93) in the null industry. This means that ADMA’s stock grew similarly to ARTL’s over the last 12 months.

ADMA's P/E Growth Rating (78) in the Biotechnology industry is in the same range as ARTL (100) in the null industry. This means that ADMA’s stock grew similarly to ARTL’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ADMAARTL
RSI
ODDS (%)
Bearish Trend 3 days ago
69%
Bearish Trend 2 days ago
75%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
70%
Momentum
ODDS (%)
Bearish Trend 2 days ago
74%
Bearish Trend 2 days ago
89%
MACD
ODDS (%)
Bearish Trend 2 days ago
70%
Bearish Trend 2 days ago
83%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
78%
Bearish Trend 2 days ago
87%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
77%
Bearish Trend 2 days ago
88%
Advances
ODDS (%)
Bullish Trend 9 days ago
83%
Bullish Trend about 1 month ago
76%
Declines
ODDS (%)
Bearish Trend 2 days ago
74%
Bearish Trend 2 days ago
89%
BollingerBands
ODDS (%)
N/A
Bearish Trend 2 days ago
77%
Aroon
ODDS (%)
N/A
Bearish Trend 2 days ago
89%
COMPARISON
Comparison
Sep 13, 2026
Stock price -- (ADMA: $9.23 vs. ARTL: $5.43)
Brand notoriety: ADMA and ARTL are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ADMA: 80% vs. ARTL: 104%
Market capitalization -- ADMA: $2.07B vs. ARTL: $2.93M
ADMA [@Biotechnology] is valued at $2.07B. ARTL’s [@Biotechnology] market capitalization is $2.93M. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $130.64B. The average market capitalization across the [@Biotechnology] industry is $2.24B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ADMA’s FA Score shows that 1 FA rating(s) are green while ARTL’s FA Score has 1 green FA rating(s).

  • ADMA’s FA Score: 1 green, 4 red.
  • ARTL’s FA Score: 1 green, 4 red.
According to our system of comparison, ADMA is a better buy in the long-term than ARTL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ADMA’s TA Score shows that 2 TA indicator(s) are bullish while ARTL’s TA Score has 2 bullish TA indicator(s).

  • ADMA’s TA Score: 2 bullish, 4 bearish.
  • ARTL’s TA Score: 2 bullish, 8 bearish.
According to our system of comparison, ADMA is a better buy in the short-term than ARTL.

Price Growth

ADMA (@Biotechnology) experienced а -4.05% price change this week, while ARTL (@Biotechnology) price change was -10.10% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -6.09%. For the same industry, the average monthly price growth was -3.45%, and the average quarterly price growth was +2531.70%.

Reported Earning Dates

ADMA is expected to report earnings on Nov 11, 2026.

ARTL is expected to report earnings on Nov 17, 2026.

Industries' Descriptions

@Biotechnology (-6.09% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
ADMA
Daily Signal:
Gain/Loss:
ARTL
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RBA83.603.06
+3.80%
RB Global
MMLP2.180.01
+0.46%
Martin Midstream Partners LP
FBK54.76-0.18
-0.33%
FB Financial Corp
CIIT2.75-0.03
-1.08%
Tianci International Inc
NKLR5.11-0.14
-2.67%
Terra Innovatum Global N.V.

ADMA and

Correlation & Price change

A.I.dvisor indicates that over the last year, ADMA has been loosely correlated with VCYT. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if ADMA jumps, then VCYT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ADMA
1D Price
Change %
ADMA100%
-1.70%
VCYT - ADMA
36%
Loosely correlated
-2.76%
ENGN - ADMA
35%
Loosely correlated
+1.69%
AMRN - ADMA
34%
Loosely correlated
-1.71%
TAOX - ADMA
33%
Loosely correlated
+2.63%
AXON - ADMA
32%
Poorly correlated
+0.10%
More

ARTL and

Correlation & Price change

A.I.dvisor indicates that over the last year, ARTL has been loosely correlated with PALI. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if ARTL jumps, then PALI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ARTL
1D Price
Change %
ARTL100%
-3.55%
PALI - ARTL
34%
Loosely correlated
+2.49%
CRMD - ARTL
32%
Poorly correlated
-1.70%
FATE - ARTL
31%
Poorly correlated
-0.86%
ADMA - ARTL
30%
Poorly correlated
-1.70%
LSTA - ARTL
29%
Poorly correlated
-0.61%
More